BioStem Technologies (BSEM) CCO details stock, option and RSU holdings
Rhea-AI Filing Summary
BioStem Technologies, Inc. reported the initial equity holdings of Chief Commercial Officer Barry Hassett. He directly holds 4,503 shares of Common Stock. He also holds stock options to acquire Common Stock, including options over 11,417 shares at $14.89 expiring February 1, 2035; 2,427 shares at $14.89 expiring October 13, 2035; and 70,485 shares at $5.50 expiring February 11, 2036, each subject to time-based vesting schedules.
In addition, he holds restricted stock units (each representing a right to receive one share of Common Stock) covering 4,997, 1,519, and 58,182 underlying shares, with vesting in quarterly installments over multi‑year periods beginning on grant anniversaries in 2026 and 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
7 transactions reported
Mixed
7 txns
Insider
HASSETT BARRY
Role
Chief Commercial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) F1 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F2 | -- | -- | -- |
| holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
| holding | Restricted Stock Units F5, F4 | -- | -- | -- |
| holding | Restricted Stock Units F5, F6 | -- | -- | -- |
| holding | Restricted Stock Units F5, F7 | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 84,329 shares (Direct);
Restricted Stock Units — 64,698 shares (Direct);
Common Stock — 4,503 shares (Direct)
Footnotes (7)
- F1. These options vest according to the following schedule: 33% vested on February 1, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F2. These options vest according to the following schedule: 33% will vest on October 13, 2026, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F3. These options vest according to the following schedule: 33% will vest on February 11, 2027, the one-year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F4. These restricted stock units vest in equal quarterly installments over four years from the grant date (December 9, 2024).
- F5. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F6. These restricted stock units vest according to the following schedule: 33% vested on February 1, 2026, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.
- F7. These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly installments over the subsequent two year period.
Key Figures
Direct Common Shares: 4,503 shares
Option at $14.89 expiring 2035-02-01: 11,417 underlying shares
Option at $14.89 expiring 2035-10-13: 2,427 underlying shares
+4 more
7 metrics
Direct Common Shares
4,503 shares
Common Stock directly held by Barry Hassett
Option at $14.89 expiring 2035-02-01
11,417 underlying shares
Stock Option (Right to Buy) on Common Stock
Option at $14.89 expiring 2035-10-13
2,427 underlying shares
Stock Option (Right to Buy) on Common Stock
Option at $5.50 expiring 2036-02-11
70,485 underlying shares
Stock Option (Right to Buy) on Common Stock
RSU award 1
4,997 underlying shares
Restricted Stock Units vesting quarterly over four years from December 9, 2024
RSU award 2
1,519 underlying shares
Restricted Stock Units with 33% vested on February 1, 2026 then quarterly over two years
RSU award 3
58,182 underlying shares
Restricted Stock Units vesting 33% on February 11, 2027 then quarterly over two years
Key Terms
Restricted Stock Units, Stock Option (Right to Buy), underlying security shares, vesting in equal quarterly installments, +1 more
5 terms
Restricted Stock Units financial
"These restricted stock units vest in equal quarterly installments over four years"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) with an exercise price of 5.5000"
vesting in equal quarterly installments financial
"with the remaining options vesting in equal quarterly installments"
FAQ
What does the BioStem Technologies (BSEM) Form 3 for Barry Hassett show?
The Form 3 shows Chief Commercial Officer Barry Hassett’s initial equity holdings, including 4,503 common shares, several stock option positions, and multiple restricted stock unit (RSU) awards subject to time-based vesting schedules extending into 2027 and beyond.
What stock options does Barry Hassett hold in BioStem Technologies (BSEM)?
He holds options on 11,417 shares at $14.89 expiring February 1, 2035, 2,427 shares at $14.89 expiring October 13, 2035, and 70,485 shares at $5.50 expiring February 11, 2036, all vesting 33% after one year then quarterly over two years.
What restricted stock units does Barry Hassett hold in BioStem Technologies (BSEM)?
He holds RSUs over 4,997, 1,519, and 58,182 shares of common stock. One award vests quarterly over four years from December 9, 2024, and others vest 33% on first grant anniversaries in 2026 and 2027, then quarterly over two years.
How do Barry Hassett’s BioStem (BSEM) options and RSUs vest?
The options generally vest 33% on the first anniversary of the grant date, with remaining options vesting in equal quarterly installments over the next two years. RSUs vest either quarterly over four years or 33% at one year, then quarterly over two years.
Does Barry Hassett’s Form 3 for BioStem Technologies (BSEM) show any stock sales or purchases?
No stock sales or purchases are shown. The Form 3 lists holdings only: common shares, stock options, and RSUs. The transaction codes and summary do not indicate any buys or sells, only existing positions and their vesting terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
